Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Apr;32(4):485-7.
doi: 10.1128/AAC.32.4.485.

Pharmacokinetics of cefonicid in patients with skin and skin structure infections

Affiliations

Pharmacokinetics of cefonicid in patients with skin and skin structure infections

K L Heim-Duthoy et al. Antimicrob Agents Chemother. 1988 Apr.

Abstract

The disposition of cefonicid (2 g intravenously every 24 h) was assessed in 15 patients with skin and skin structure infections. Trough and peak concentrations in serum were measured on two successive days to verify the attainment of steady state; and 1 trough and 12 postdose values of the concentration in serum were collected on the following day. Cefonicid concentrations in serum were determined by high-performance liquid chromatography. The cefonicid serum concentration versus time profile after intravenous infusion was clearly biexponential in all patients. The terminal elimination half-life determined by nonlinear regression analysis was 4.63 +/- 1.49 h (mean +/- standard deviation). The steady-state volume of distribution and total body clearance were 0.12 +/- 0.04 liter/kg and 0.369 +/- 0.110 ml/min per kg, respectively. These results are comparable to parameters derived from previous studies in noninfected normal volunteers. Thus, the disposition of cefonicid is not altered in patients with severe skin and skin structure infections.

PubMed Disclaimer

References

    1. Nephron. 1976;16(1):31-41 - PubMed
    1. Antimicrob Agents Chemother. 1982 Jun;21(6):935-8 - PubMed
    1. Antimicrob Agents Chemother. 1983 Jan;23(1):125-32 - PubMed
    1. J Pharm Sci. 1983 Aug;72(8):978-9 - PubMed
    1. Am J Kidney Dis. 1983 Nov;3(3):155-93 - PubMed